The contribution of CYP1A2 to the formation of DNA adducts of the cooked meat-derived heterocyclic amines (HCAs) 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) was examined in CYP1A2-null (knock-out, KO) and wild-type (WT) mice. IQ (25 mg and 75 mg/kg) and PhIP (150 mg/kg) were administered by gavage to mice and DNA adduct levels in liver, kidney, mammary gland and colon were examined by the 32P-postlabeling assay. Three hours after either dose of IQ, adducts levels in liver and kidney of KO mice were 20-30% the levels in WT mice, a difference that was statistically significant (Student's t-test, p<0.05). In colon, adduct levels in KO mice were significantly lower than in the WT mice only at the lowest dose of IQ (1.6 + 0.6 versus 4.6 + 0.7, respectively, relative adduct labeling (RAL) x 108, mean + SEM, n=3-5 mice). In mammary gland, however, there was no difference in IQ-DNA adduct levels in KO and WT mice at either dose of IQ. Three hours after dosing with PhIP, PhIP-DNA adduct levels were statistically significantly lower in KO mice than in WT mice in all tissues examined. PhIP-DNA adducts in liver and kidney of WT mice were 9.9 + 1.1 and 22.5 + 6.9, respectively, whereas no PhIP-DNA adducts were detected in either organ of KO mice (limit of detection, 1.4-2.8 x 109). PhIP-DNA adduct levels in mammary gland and colon of WT mice were 47.1 + 9.5 and 58.0 + 21.7, respectively, but accordingly only 3.8 + 0.7 and 5.4 + 0.9 in KO mice. The findings indicate that CYP1A2, responsible for IQ and PhIP N-hydroxylation, the first step in the metabolic action, significantly effects DNA adduct formation in vivo. However, the data raise the possibility that other cytochromes P450 as well as other pathways of activation potentially contribute to DNA adduct formation in specific organs, depending on the HCA substrate. Using the HC11 mouse mammary epithelial cell line, a well-characterized model for hormone-mediated differentiation, we examined whether PhIP altered the expression of genes regulated by lactogenic hormones dexamethasone, insulin, and prolactin (DIP). When HC-11-Lux cells (stably transfected with a b-casein promoter luciferase construct) were cultured in DIP-containing medium, PhIP (100 mM) enhanced luciferase activity 11-fold over that observed in DIP medium alone. The effect of PhIP on augmenting luciferase activity was observed only when lactogenic hormones were included in the medium. Expression of the endogenous b-casein gene was also higher in HC11 cells treated with PhIP in hormone-enriched medium. With the increased expression of b-casein gene, the level of phospho-STAT5A, the transcription factor regulating b-casein gene expression, was elevated in PhIP-exposed HC11 cells. AG490, a JAK2-specific inhibitor, blocked the effect of PhIP on b-casein gene expression. PhIP-treated cells also showed higher expression of Bcl-2 and lower expression of Bax, consistent with a possible anti-apoptotic action of PhIP. The findings indicate that PhIP modulates lactogenic hormone-mediated gene expression in mammary epithelial cells, apparently via enhanced phosphorylation of STAT5A. The findings have implications for a novel mechanism of action of the mammary gland carcinogen PhIP.

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC010037-08
Application #
6950920
Study Section
(LEC)
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Qiu, Cunping; Shan, Liang; Yu, Minshu et al. (2005) Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Carcinogenesis 26:763-9
Shan, Liang; Yu, Minshu; Snyderwine, Elizabeth G (2005) Gene expression profiling of chemically induced rat mammary gland cancer. Carcinogenesis 26:503-9
Shan, Liang; Yu, Minshu; Clark, Bradly D et al. (2004) Possible role of Stat5a in rat mammary gland carcinogenesis. Breast Cancer Res Treat 88:263-72
Qiu, Cunping; Shan, Liang; Yu, Minshu et al. (2003) Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res 63:5674-8
Qiu, Cunping; Yu, Minshu; Shan, Liang et al. (2003) Allelic imbalance and altered expression of genes in chromosome 2q11-2q16 from rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Oncogene 22:1253-60
Venugopal, M; Callaway, A; Snyderwine, E G (1999) 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) retards mammary gland involution in lactating Sprague-Dawley rats. Carcinogenesis 20:1309-14
Venugopal, M; Agarwal, R; Callaway, A et al. (1999) Inhibition of cell death in human mammary epithelial cells by the cooked meat-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Biochem Biophys Res Commun 266:203-7
Schut, H A; Snyderwine, E G (1999) DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis 20:353-68
Snyderwine, E G (1999) Mammary gland carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats: possible mechanisms. Cancer Lett 143:211-5